Evidence map›Paper›PMID 20221253›Full record

ArticlePLoS genetics2010

PPS, a large multidomain protein, functions with sex-lethal to regulate alternative splicing in Drosophila.

Matthew L Johnson, Alexis A Nagengast, Helen K Salz

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Role of Hakai in mNature communications · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Xio is a component of theProceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. spenito is required for sex determination in Drosophila melanogaster.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  18. Article
  19. Article
  20. Sex-lethal enables germline stem cell differentiation by down-regulating Nanos protein levels during Drosophila oogenesis.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Matthew L JohnsonDepartment of Genetics, Case Western Reserve University, School of Medicine, Cleveland, Ohio, United States of America.
Alexis A Nagengast
Helen K Salz
Case Western Reserve University · USUniversity School · US

Funding

TRAINING IN NORMAL AND ABNORMAL DEVELOPMENTT32HD007104 · NICHD · CASE WESTERN RESERVE UNIVERSITY · PI HARTE, PETER J. · 1985 to 2010
$3.5M
TRAINING IN GENETICST32GM008613 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI SALZ, HELEN KAREN · 1996 to 2010
$3.1M
Regulation of Sex-lethal pre-mRNA splicing during Drosophila developmentR01GM061039 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI SALZ, HELEN KAREN · 2002 to 2010
$2.5M
NICHD NIH HHS T32 HD007104NICHD NIH HHS T32-HD07104NIGMS NIH HHS R01 GM061039NIGMS NIH HHS R01-GM61039NIGMS NIH HHS T32 GM008613NIGMS NIH HHS T32-GM008613
6 · The paper itself

Abstract

Alternative splicing controls the expression of many genes, including the Drosophila sex determination gene Sex-lethal (Sxl). Sxl expression is controlled via a negative regulatory mechanism where inclusion of the translation-terminating male exon is blocked in females. Previous studies have shown that the mechanism leading to exon skipping is autoregulatory and requires the SXL protein to antagonize exon inclusion by interacting with core spliceosomal proteins, including the U1 snRNP protein Sans-fille (SNF). In studies begun by screening for proteins that interact with SNF, we identified PPS, a previously uncharacterized protein, as a novel component of the machinery required for Sxl male exon skipping. PPS encodes a large protein with four signature motifs, PHD, BRK, TFS2M, and SPOC, typically found in proteins involved in transcription. We demonstrate that PPS has a direct role in Sxl male exon skipping by showing first that loss of function mutations have phenotypes indicative of Sxl misregulation and second that the PPS protein forms a complex with SXL and the unspliced Sxl RNA. In addition, we mapped the recruitment of PPS, SXL, and SNF along the Sxl gene using chromatin immunoprecipitation (ChIP), which revealed that, like many other splicing factors, these proteins bind their RNA targets while in close proximity to the DNA. Interestingly, while SNF and SXL are specifically recruited to their predicted binding sites, PPS has a distinct pattern of accumulation along the Sxl gene, associating with a region that includes, but is not limited to, the SxlPm promoter. Together, these data indicate that PPS is different from other splicing factors involved in male-exon skipping and suggest, for the first time, a functional link between transcription and SXL-mediated alternative splicing. Loss of zygotic PPS function, however, is lethal to both sexes, indicating that its role may be of broad significance.

Indexed as

Alternative SplicingAnimalsDrosophila melanogasterDrosophila ProteinsEmbryo, NonmammalianFemaleGene DosageGenes, EssentialMaleMutationNuclear ProteinsOvaryPromoter Regions, GeneticProtein BindingProtein Structure, TertiaryRibonucleoprotein, U1 Small NuclearDrosophila ProteinsNuclear Proteinspps protein, DrosophilaRibonucleoprotein, U1 Small NuclearRNA-Binding ProteinsRNA Precursorssnf protein, DrosophilaSxl protein, DrosophilaTranscription FactorsTra protein, Drosophila

Identifiers

PMID20221253
PMCPMC2832672
OpenAlexW2063113536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.